ZBH Stock Summary and Trading Ideas (Zimmer Biomet Holdings | NYSE:ZBH)

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Zimmer Biomet Holdings trades on the NYSE stock market under the symbol ZBH.

As of January 15, 2026, ZBH stock price declined to $88.60 with 1,306,815 million shares trading.

ZBH has a beta of 0.63, meaning it tends to be less sensitive to market movements. ZBH has a correlation of 0.14 to the broad based SPY ETF.

ZBH has a market cap of $17.55 billion. This is considered a Large Cap stock.

Last quarter Zimmer Biomet Holdings reported $2 billion in Revenue and $1.90 earnings per share. This fell short of revenue expectation by $-9 million and exceeded earnings estimates by $.03.

In the last 3 years, ZBH traded as high as $149.25 and as low as $85.33.

The top ETF exchange traded funds that ZBH belongs to (by Net Assets): VTI, VOO, VO, MOAT, IVV.

ZBH has underperformed the market in the last year with a price return of -14.5% while the SPY ETF gained +20.5%. ZBH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.7% and -1.5%, respectively, while the SPY returned +5.1% and +1.8%, respectively.

ZBH support price is $87.72 and resistance is $90.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZBH shares will trade within this expected range on the day.